Intervention Review

Amisulpride for schizophrenia

  1. Joaquim I Silveira da Mota Neto1,*,
  2. Bernardo GO Soares2,
  3. Mauricio Silva de Lima3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 22 APR 2002

Assessed as up-to-date: 22 JAN 2002

DOI: 10.1002/14651858.CD001357

How to Cite

Silveira da Mota Neto JI, Soares BGO, Silva de Lima M. Amisulpride for schizophrenia. Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD001357. DOI: 10.1002/14651858.CD001357.

Author Information

  1. 1

    Universidade Federal de Pelotas, Evidence Based Medicine Centre, Pelotas, Brazil

  2. 2

    Universidade Federal de São Paulo, Brazilian Cochrane Centre, São Paulo, São Paulo, Brazil

  3. 3

    Eli Lilly & Co, Medical, Basingstoke, Hampshire, UK

*Joaquim I Silveira da Mota Neto, Evidence Based Medicine Centre, Universidade Federal de Pelotas, Avenida Duque de Caxias, 250, Pelotas, 96100, Brazil.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 22 APR 2002


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.